ATE297900T1 - Anilidverbindungen und medikamente, die diese enthalten - Google Patents
Anilidverbindungen und medikamente, die diese enthaltenInfo
- Publication number
- ATE297900T1 ATE297900T1 AT98911008T AT98911008T ATE297900T1 AT E297900 T1 ATE297900 T1 AT E297900T1 AT 98911008 T AT98911008 T AT 98911008T AT 98911008 T AT98911008 T AT 98911008T AT E297900 T1 ATE297900 T1 AT E297900T1
- Authority
- AT
- Austria
- Prior art keywords
- substituent
- lower alkyl
- alkyl group
- aryl group
- atom
- Prior art date
Links
- -1 ANILIDE COMPOUNDS Chemical class 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 6
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 abstract 1
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 abstract 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 abstract 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005516 coenzyme A Substances 0.000 abstract 1
- 229940093530 coenzyme a Drugs 0.000 abstract 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- 150000003457 sulfones Chemical class 0.000 abstract 1
- 150000003462 sulfoxides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9014697 | 1997-03-25 | ||
| PCT/JP1998/001337 WO1998042680A1 (en) | 1997-03-25 | 1998-03-25 | Novel anilide compounds and drugs containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE297900T1 true ATE297900T1 (de) | 2005-07-15 |
Family
ID=13990371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98911008T ATE297900T1 (de) | 1997-03-25 | 1998-03-25 | Anilidverbindungen und medikamente, die diese enthalten |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6362208B1 (de) |
| EP (1) | EP1020451B1 (de) |
| JP (1) | JP4647726B2 (de) |
| AT (1) | ATE297900T1 (de) |
| AU (1) | AU6517698A (de) |
| DE (1) | DE69830600T2 (de) |
| ES (1) | ES2245026T3 (de) |
| WO (1) | WO1998042680A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6969711B2 (en) | 1997-05-26 | 2005-11-29 | Kowa Company, Ltd. | Cyclic diamine compounds and medicine containing the same |
| WO1998054153A1 (en) * | 1997-05-26 | 1998-12-03 | Kowa Company, Ltd. | Novel cyclic diamine compounds and medicine containing the same |
| JP2003012647A (ja) * | 2000-10-04 | 2003-01-15 | Shionogi & Co Ltd | ２，３−ジアミノピリジンの製造方法 |
| US7163944B2 (en) * | 2004-01-26 | 2007-01-16 | Kowa Co., Ltd. | Cyclic diamine compound and pharmaceutical containing the same |
| WO2019023635A1 (en) * | 2017-07-27 | 2019-01-31 | Stingray Therapeutics, Inc. | SUBSTITUTED 3 H-IMIDAZO (4,5-C) PYRIDINE AND 1H-PYRROLO (2,3-C) PYRIDINE SERIES OF A NOVEL ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE-1 (ENPP1) AND STIMULATOR FOR A GENE MODULATOR INTERFERON (STING) AS IMMUNOTHERAPEUTIC AGENTS AGAINST CANCER |
| WO2020028724A1 (en) | 2018-08-01 | 2020-02-06 | Stingray Therapeutics, Inc. | Substituted-3h-imidazo[4,5-c]pyridine and 1h-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (enpp1) and stimulator for interferon genes (sting) modulators as cancer immunotherapeutics |
| EP4262790A1 (de) * | 2020-12-15 | 2023-10-25 | Royal College of Surgeons in Ireland | Selektiver hdac6-hemmer |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE744970A (fr) | 1969-01-28 | 1970-07-27 | Lilly Co Eli | Agents antiviraux et immuno-depresseurs |
| US3720686A (en) * | 1971-04-01 | 1973-03-13 | Squibb & Sons Inc | Mercaptobenzimidazole derivatives |
| FR2148362A1 (en) | 1971-08-11 | 1973-03-23 | Ferlux | 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity |
| FR2190426A1 (en) * | 1972-06-27 | 1974-02-01 | Ferlux | Derivs of pyrido oxazolyl thiocarboxylic acids - analgesics hypotensives and choleretics, prepd from 2-mercapto oxazolo pyridine and halo acid deriv |
| DE2422700A1 (de) * | 1974-05-10 | 1975-11-20 | Walentin Nikolajewitsc Ufimzew | Disperse monoazofarbstoffe und verfahren zu ihrer herstellung |
| US4088768A (en) | 1975-05-06 | 1978-05-09 | Eli Lilly And Company | N-heterocyclic ureas as immune regulants |
| DE2961415D1 (en) * | 1978-05-20 | 1982-01-28 | Bayer Ag | Heteroaryloxy-acetamides, process for their preparation and their use as herbicides |
| US4265900A (en) | 1979-10-29 | 1981-05-05 | Mcneilab, Inc. | N-Aryl-N'-imidazol-2-ylureas |
| JPS57183764A (en) * | 1981-04-06 | 1982-11-12 | Nippon Tokushu Noyaku Seizo Kk | Substituted acetanilide compound, its preparation, and herbicide |
| JPS58116489A (ja) * | 1981-12-28 | 1983-07-11 | Otsuka Pharmaceut Factory Inc | カルボン酸アミド誘導体 |
| FR2636064B1 (fr) * | 1988-09-08 | 1990-12-07 | Fabre Sa Pierre | Thioformamidines, leur preparation et leur application en tant que medicaments |
| CA2003283A1 (en) * | 1988-12-05 | 1990-06-05 | C. Anne Higley | Imidazoles for the treatment of atherosclerosis |
| US5166214A (en) * | 1988-12-05 | 1992-11-24 | Du Pont Merck Pharmaceutical Company | Use of imidazoles for the treatment of atherosclerosis |
| IT1227527B (it) | 1988-12-05 | 1991-04-12 | Ciatti Maurizio | Spazzolino da denti a setole rotanti |
| JPH04139172A (ja) * | 1990-10-01 | 1992-05-13 | Sankyo Co Ltd | α―スルフィニル置換アセトアミド誘導体 |
| US5162360A (en) * | 1991-06-24 | 1992-11-10 | Warner-Lambert Company | 2-heteroatom containing urea and thiourea ACAT inhibitors |
| US5290801A (en) * | 1992-05-29 | 1994-03-01 | The Du Pont Merck Pharmaceutical Company | Benzimidazoles for the treatment of atherosclerosis |
| US5700819A (en) * | 1994-11-29 | 1997-12-23 | Grelan Pharmaceutical Co., Ltd. | 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications |
| JP4191269B2 (ja) * | 1996-05-17 | 2008-12-03 | 興和株式会社 | 新規なアニリド化合物及びこれを含有する医薬 |
| AU6144098A (en) * | 1997-02-14 | 1998-09-08 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
| JP2000510870A (ja) * | 1997-02-14 | 2000-08-22 | バイエル・コーポレーシヨン | Ｎｐｙ５受容体アンタゴニストとしてのアミド類 |
| US5886191A (en) * | 1997-08-18 | 1999-03-23 | Dupont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof |
-
1998
- 1998-03-25 AT AT98911008T patent/ATE297900T1/de not_active IP Right Cessation
- 1998-03-25 JP JP54544398A patent/JP4647726B2/ja not_active Expired - Fee Related
- 1998-03-25 AU AU65176/98A patent/AU6517698A/en not_active Abandoned
- 1998-03-25 WO PCT/JP1998/001337 patent/WO1998042680A1/ja not_active Ceased
- 1998-03-25 DE DE69830600T patent/DE69830600T2/de not_active Expired - Lifetime
- 1998-03-25 EP EP98911008A patent/EP1020451B1/de not_active Expired - Lifetime
- 1998-03-25 US US09/381,850 patent/US6362208B1/en not_active Expired - Fee Related
- 1998-03-25 ES ES98911008T patent/ES2245026T3/es not_active Expired - Lifetime
-
2001
- 2001-12-19 US US10/034,669 patent/US6797717B2/en not_active Expired - Fee Related
-
2002
- 2002-02-20 US US10/079,641 patent/US20030087928A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1020451A1 (de) | 2000-07-19 |
| WO1998042680A1 (en) | 1998-10-01 |
| AU6517698A (en) | 1998-10-20 |
| US20030087928A1 (en) | 2003-05-08 |
| EP1020451B1 (de) | 2005-06-15 |
| US20020099074A1 (en) | 2002-07-25 |
| DE69830600D1 (de) | 2005-07-21 |
| EP1020451A4 (de) | 2001-06-13 |
| US6362208B1 (en) | 2002-03-26 |
| JP4647726B2 (ja) | 2011-03-09 |
| DE69830600T2 (de) | 2006-05-04 |
| US6797717B2 (en) | 2004-09-28 |
| ES2245026T3 (es) | 2005-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0987254A4 (de) | Neue zyklische diaminverbindungen und heilmittel das diese enthält | |
| BR0116539A (pt) | Derivados de piridona tendo uma atividade de ligação para o receptor 2 do tipo canabinóide | |
| LV12606A (lv) | Okssiiminoalkanskabes atvasinajumi | |
| DE60232739D1 (de) | Aktivator des peroxisomproliferator-aktivierten rezeptors delta | |
| ATE327230T1 (de) | Piperidinverbindungen und diese enthaltenden medikamente | |
| FI943561A0 (fi) | Uudet ainekoostumukset | |
| ATE321759T1 (de) | Neue amidverbindungen und medikamente die diese enthalten | |
| EP1357115A4 (de) | Alkansäurederivate, verfahren zu deren herstellung und deren verwendung | |
| DE69609948D1 (de) | Flüssigkristallzusammensetzungen und flüssigkristallanzeigeelemente | |
| ATE314352T1 (de) | Anilide als acat-hemmer | |
| ATE372320T1 (de) | Cyclische amidderivate | |
| FI971227A0 (fi) | Pyramidinyylipyratsolijohdannaisia | |
| DE69830600D1 (de) | Anilidverbindungen und medikamente, die diese enthalten | |
| ATE257139T1 (de) | Ein (1'r,2's,5'r)-3-l-menthoxypropan-1-ol, das eine kühlende empfindung erzeugt | |
| KR970702848A (ko) | 아릴피페리딘 및 아릴피페라진 유도체 및 이를 함유하는 약제(Arylpiperidine and arylpiperazine derivatives and drugs containing the same) | |
| BR0207966A (pt) | Composição farmacêutica contendo derivados 1,3-tiazina | |
| WO2003075928A3 (en) | Stable pharmaceutical compositions | |
| DE3781986D1 (de) | Substituierte chinoxaline. | |
| DE3778088D1 (de) | Substituierte pyrimidochinoxaline. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |